||Ribeiro, VGC; Mendonça, VA; Souza, ALC; Fonseca, SF; Camargos, ACR; Lage, VKS; Neves, CDC; Santos, JM; Teixeira, LAC; Vieira, ELM; Teixeira Junior, AL; Mezêncio, B; Fernandes, JSC; Leite, HR; Poortmans, JR; Lacerda, ACR.|
||Inflammatory biomarkers responses after acute whole body vibration in fibromyalgia|
||Braz. j. med. biol. res = Rev. bras. pesqui. méd. biol;51(4):e6775, 2018. tab, graf.
||FAPEMIG; . CNPq.
||The aims of this study were 1) to characterize the intensity of the vibration stimulation in women diagnosed with fibromyalgia (FM) compared to a control group of healthy women (HW) matched by age and anthropometric parameters, and 2) to investigate the effect of a single session of whole body vibration (WBV) on inflammatory responses. Levels of adipokines, soluble tumor necrosis factor receptors (sTNFr1, sTNFr2), and brain-derived neurotrophic factor (BDNF) were determined by enzyme-linked immunosorbent assay. Oxygen consumption (VO2) was estimated by a portable gas analysis system, heart rate (HR) was measured using a HR monitor, and perceived exertion (RPE) was evaluated using the Borg scale of perceived exertion. Acutely mild WBV increased VO2 and HR similarly in both groups. There was an interaction (disease vs vibration) in RPE (P=0.0078), showing a higher RPE in FM compared to HW at rest, which further increased in FM after acute WBV, whereas it remained unchanged in HW. In addition, there was an interaction (disease vs vibration) in plasma levels of adiponectin (P=0.0001), sTNFR1 (P=0.000001), sTNFR2 (P=0.0052), leptin (P=0.0007), resistin (P=0.0166), and BDNF (P=0.0179). In conclusion, a single acute session of mild and short WBV can improve the inflammatory status in patients with FM, reaching values close to those of matched HW at their basal status. The neuroendocrine mechanism seems to be an exercise-induced modulation towards greater adaptation to stress response in these patients.|
Mediadores da Inflamação/sangue
||-Consumo de Oxigênio/fisiologia|
Ensaio de Imunoadsorção Enzimática
Estudos de Casos e Controles
Receptores do Fator de Necrose Tumoral/sangue
Fator Neurotrófico Derivado do Encéfalo/sangue
||BR1.1 - BIREME|